David Weinstein, MD, MSc
Director, Glycogen Storage Disease Program
Practice Name: Connecticut Children's Specialty Group
Education: BS, Trinity College, 1990
MD, Harvard Medical School, 1994
MMSc, Massachusetts Institute of Technology/Harvard Medical School, 2002
Residency: Pediatrics, Children’s Hospital Boston, 1994-1997
Chief Resident, Children’s Hospital Boston, 1997-1998
Fellowship: Endocrinology, Children’s Hospital Boston, 1998-2001
Other: Clinical Investigator Training Program, MIT/Harvard, 2000-2002
Professor, University of Connecticut School of Medicine
Dr. Weinstein specializes in disorders of carbohydrate metabolism with particular focus on glycogen storage disease, hypoglycemia, and diabetes.
As the director of the glycogen storage disease program, he manages the in-patient and out-patient care the largest cohort of GSD patients in the world following over 500 people with this disorder. Of these, over 225 patients have glycogen storage disease type Ia, 70 patients have glycogen storage disease type Ib, 50 patients have type III glycogen storage disease, and over 200 patients with types 0, VI, or IX GSD.
His patients come from over 49 states and 45 countries to be cared for by him. Dr. Weinstein attends for the majority of glycogen storage disease in-patient evaluations.
- Gene therapy for glycogen storage disease
- Understanding the pathophysiology of hypoglycemia in children with a focus on the causes of ketotic hypoglycemia
- Investigation into the cause of morbidity type 0 and I glycogen storage disease including the pathophysiology of hepatic adenomas, hepatocellular carcinoma, nephrolithiasis, anemia, and focal segmental glomerulosclerosis
- Investigation of new medical treatments for glycogen storage disease